Though the precise function of GFAT in tumor progression remains not defined, several previous studies have shown the anti-neoplastic properties of GFAT inhibitors DON and azaserine [22, 23], suggesting a potential role of GFAT in driving tumorigenesis. The gene discussed is GFPT2; the disease is neoplasm.